Item 16. FORM 10-K SUMMARY

3K characters. Original on sec.gov · Markdown

Item 16. FORM 10-K SUMMARY

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: February 15, 2022

UNITEDHEALTH GROUP INCORPORATED
By/s/ ANDREW P. WITTY
Andrew P. Witty Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SignatureTitleDate
/s/ ANDREW P. WITTYDirector and Chief Executive Officer (principal executive officer)February 15, 2022
Andrew P. Witty
/s/ JOHN F. REXExecutive Vice President and Chief Financial Officer (principal financial officer)February 15, 2022
John F. Rex
/s/ THOMAS E. ROOSSenior Vice President and Chief Accounting Officer (principal accounting officer)February 15, 2022
Thomas E. Roos
*DirectorFebruary 15, 2022
Richard T. Burke
*DirectorFebruary 15, 2022
Timothy P. Flynn
*DirectorFebruary 15, 2022
Paul R. Garcia
*DirectorFebruary 15, 2022
Stephen J. Hemsley
*DirectorFebruary 15, 2022
Michele J. Hooper
*DirectorFebruary 15, 2022
F. William McNabb III
*DirectorFebruary 15, 2022
Valerie C. Montgomery Rice, M.D.
*DirectorFebruary 15, 2022
John H. Noseworthy, M.D.
*DirectorFebruary 15, 2022
Gail R. Wilensky, Ph.D.
*By/s/ DANNETTE L. SMITH
Dannette L. Smith As Attorney-in-Fact

Previous: Item 15. EXHIBIT AND FINANCIAL STATEMENT SCHEDULES